List of COVID-19 vaccine authorizations: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
lead and maps copied from COVID-19 vaccine
text derived from COVID-19 table
Line 19: Line 19:


== Pfizer–BioNTech ==
== Pfizer–BioNTech ==
The [[Pfizer–BioNTech COVID-19 vaccine]], also known as Comirnaty, is an [[RNA vaccine]]<ref name="hcreg">{{cite web|date=9 December 2020|title=Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref> produced by the German company [[BioNTech]] and the American company [[Pfizer]].<ref name="hcreg2">{{cite web|date=9 December 2020|title=Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name="NCT04368728">{{cite web|date=30 April 2020|title=Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults|url=https://clinicaltrials.gov/ct2/show/NCT04368728|url-status=live|archive-url=https://web.archive.org/web/20201011084828/https://clinicaltrials.gov/ct2/show/NCT04368728/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368728}}</ref><ref name="EudraCT-2020-001038-36">{{cite web|date=14 April 2020|title=A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|url-status=live|archive-url=https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|archive-date=22 April 2020|access-date=22 April 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001038-36}}</ref>

;Emergency (36)
;Emergency (36)
{{Div col}}
{{Div col}}
Line 75: Line 75:


== Sputnik V ==
== Sputnik V ==
The [[Sputnik V COVID-19 vaccine]] is a [[viral vector]] vaccine<ref name="NCT04436471">{{cite web|date=17 June 2020|title=An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04436471|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04436471}}</ref> produced by the Russan [[Gamaleya Research Institute of Epidemiology and Microbiology]].

;Emergency (44)
;Emergency (44)
{{Div col}}
{{Div col}}
Line 135: Line 135:


== Oxford–AstraZeneca ==
== Oxford–AstraZeneca ==
The [[Oxford–AstraZeneca COVID-19 vaccine]], also known as Covishield, is a [[viral vector]] vaccine<ref name="NCT044008382">{{cite web|date=26 May 2020|title=Investigating a Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04400838|url-status=live|archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04400838}}</ref> produced by the British [[University of Oxford]], Swedish company [[AstraZeneca]], and the [[Coalition for Epidemic Preparedness Innovations|Coalition for Epidemic Preparedness Innovations<wbr />]].<ref name="NCT044008383">{{cite web|date=26 May 2020|title=Investigating a Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04400838|url-status=live|archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04400838}}</ref><ref name="EudraCT-2020-001228-322">{{cite web|date=21 April 2020|title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|url-status=live|archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|archive-date=5 October 2020|access-date=3 August 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001228-32}}</ref><ref name="ISRCTN899514242">{{cite journal|last1=O'Reilly|first1=Peter|date=26 May 2020|title=A Phase III study to investigate a vaccine against COVID-19|doi=10.1186/ISRCTN89951424|id=ISRCTN89951424|doi-access=free|website=ISRCTN|name-list-style=vanc}}</ref>

;Emergency (42)
;Emergency (42)
{{Div col}}
{{Div col}}
Line 197: Line 197:


== BBIBP-CorV ==
== BBIBP-CorV ==
[[BBIBP-CorV]] is an [[inactivated vaccine]]<ref name="ChiCTR20000347802">{{cite journal|last1=Chen|first1=Wei|last2=Al Kaabi|first2=Nawal|date=18 July 2020|title=A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)|url=http://www.chictr.org.cn/showprojen.aspx?proj=56651|journal=Chinese Clinical Trial Registry|access-date=15 August 2020|name-list-style=vanc}}</ref> produced by the [[China National Pharmaceutical Group]] (Sinopharm).<ref name="ChiCTR20000347803">{{cite journal|last1=Chen|first1=Wei|last2=Al Kaabi|first2=Nawal|date=18 July 2020|title=A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)|url=http://www.chictr.org.cn/showprojen.aspx?proj=56651|journal=Chinese Clinical Trial Registry|access-date=15 August 2020|name-list-style=vanc}}</ref>

;Emergency (27)
;Emergency (27)
{{Div col}}
{{Div col}}
Line 234: Line 234:


== CoronaVac ==
== CoronaVac ==
[[CoronaVac]] is an [[inactivated vaccine]]<ref name="NCT043835742">{{cite web|date=12 May 2020|title=Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)|url=https://clinicaltrials.gov/ct2/show/NCT04383574|url-status=live|archive-url=https://web.archive.org/web/20201011084809/https://clinicaltrials.gov/ct2/show/NCT04383574/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04383574}}</ref> produced by the Chinese company [[Sinovac Biotech]].<ref name="NCT043835743">{{cite web|date=12 May 2020|title=Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)|url=https://clinicaltrials.gov/ct2/show/NCT04383574|url-status=live|archive-url=https://web.archive.org/web/20201011084809/https://clinicaltrials.gov/ct2/show/NCT04383574/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04383574}}</ref><ref name="NCname= nct04456595=2">{{cite web|date=2 July 2020|title=Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)|url=https://clinicaltrials.gov/ct2/show/NCT04456595|url-status=live|archive-url=https://web.archive.org/web/20201011084811/https://clinicaltrials.gov/ct2/show/NCT04456595/|archive-date=11 October 2020|access-date=3 August 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04456595}}</ref><ref name=":12">{{cite journal|last1=PT. Bio Farma|date=10 August 2020|title=A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia|url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX|journal=Registri Penyakit Indonesia|access-date=15 August 2020}}</ref>

;Emergency (20)
;Emergency (20)
{{Div col}}
{{Div col}}
Line 264: Line 264:


== Moderna ==
== Moderna ==
The [[Moderna COVID-19 vaccine]] is an [[RNA vaccine]]<ref name="NCT04283461">{{cite web|date=16 March 2020|title=Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)|url=https://clinicaltrials.gov/ct2/show/NCT04283461|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04283461}}</ref> produced by the American company [[Moderna]], the U.S. [[National Institute of Allergy and Infectious Diseases]], the U.S. [[Biomedical Advanced Research and Development Authority]], and the [[Coalition for Epidemic Preparedness Innovations]].<ref name="NCT044704272">{{cite web|date=14 July 2020|title=A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04470427|url-status=live|archive-url=https://web.archive.org/web/20201011084833/https://clinicaltrials.gov/ct2/show/NCT04470427/|archive-date=11 October 2020|access-date=27 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04470427}}</ref><ref name="palca2">{{cite news|last1=Palca|first1=Joe|date=27 July 2020|title=COVID-19 vaccine candidate heads to widespread testing in U.S.|publisher=NPR|url=https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people|url-status=live|access-date=27 July 2020|archive-url=https://web.archive.org/web/20201011084836/https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people/|archive-date=11 October 2020|name-list-style=vanc}}</ref>

;Emergency (10)
;Emergency (10)
* Andorra<ref name="Andorra vaccines"/>
* Andorra<ref name="Andorra vaccines"/>
Line 285: Line 285:


== Johnson & Johnson ==
== Johnson & Johnson ==
The [[Johnson & Johnson COVID-19 vaccine]] is a [[viral vector]] vaccine<ref>{{cite techreport|type=Briefing|date=26 February 2021|title=Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19|publisher=[[Food and Drug Administration]]|url=https://www.fda.gov/media/146217/download|page=6|access-date=6 March 2021|quote=The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein.}}</ref> produced by the American company [[Janssen Pharmaceutica]] (a subsidiary of [[Johnson & Johnson]]) and [[Beth Israel Deaconess Medical Center]].<ref name=":22">{{Cite web|date=4 August 2020|title=A Study of Ad26.COV2.S in Adults|url=https://clinicaltrials.gov/ct2/show/NCT04436276|url-status=live|archive-url=https://web.archive.org/web/20200916063346/https://clinicaltrials.gov/ct2/show/NCT04436276|archive-date=16 September 2020|access-date=23 August 2020|website=[[ClinicalTrials.gov]]}}</ref><ref name=":32">{{Cite web|title=A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants|url=https://clinicaltrials.gov/ct2/show/NCT04505722|url-status=live|archive-url=https://web.archive.org/web/20200926145744/https://clinicaltrials.gov/ct2/show/NCT04505722|archive-date=26 September 2020|website=[[ClinicalTrials.gov]]|publisher=US National Library of Medicine}}</ref>

;Emergency (8)
;Emergency (8)
* Andorra<ref name="Andorra vaccines">{{cite news|title=Informació en relació amb la vacunació contra la COVID-19|publisher=Govern d’Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date=14 March 2021}}</ref>
* Andorra<ref name="Andorra vaccines">{{cite news|title=Informació en relació amb la vacunació contra la COVID-19|publisher=Govern d’Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date=14 March 2021}}</ref>
Line 305: Line 305:


== Convidicea ==
== Convidicea ==
[[Ad5-nCoV|Convidicea]] is a [[viral vector]] vaccine<ref name="zhu7-20">{{cite journal|display-authors=6|vauthors=Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W|date=August 2020|title=Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial|journal=Lancet|volume=396|issue=10249|pages=479–88|doi=10.1016/s0140-6736(20)31605-6|issn=0140-6736|pmc=7836858|pmid=32702299|lay-url=https://blogs.sciencemag.org/pipeline/archives/2020/07/20/new-data-on-the-cansino-vaccine|doi-access=free|title-link=doi}}</ref> produced by the Chinese company [[CanSino Biologics]] and the Beijing Institute of Biotechnology of the [[Academy of Military Medical Sciences]].

;Emergency (2)
;Emergency (2)
* Mexico<ref name="AD5 mexico"/>
* Mexico<ref name="AD5 mexico"/>
Line 314: Line 314:


== Covaxin ==
== Covaxin ==
[[BBV152|Covaxin]] is an [[inactivated vaccine]]<ref>{{cite web|title=Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers|url=https://clinicaltrials.gov/ct2/show/NCT04471519|website=[[ClinicalTrials.gov]]|id=NCT04471519}}</ref> produced by the Indian company [[Bharat Biotech]] and the [[Indian Council of Medical Research]].

;Emergency (3)
;Emergency (3)
* India<ref name="NYT India" />
* India<ref name="NYT India" />
Line 324: Line 324:


== EpiVacCorona ==
== EpiVacCorona ==
[[EpiVacCorona]] is a [[peptide vaccine]] produced by the Russian [[State Research Center of Virology and Biotechnology VECTOR]]<wbr />.<ref name="NCT045275753">{{cite web|date=22 September 2020|title=Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)|url=https://clinicaltrials.gov/ct2/show/NCT04527575|access-date=16 November 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368988}}</ref>

;Emergency (1)
;Emergency (1)
* Russia<ref>{{cite web | title = О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона" | website=Rospotrebnadzor |url = https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 |date=14 October 2020 |language=ru}}</ref><ref>{{cite web | title = Russia's EpiVacCorona vaccine post-registration trials started | publisher=The Pharma Letter |url = https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started |date=18 November 2020 }}</ref>
* Russia<ref>{{cite web | title = О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона" | website=Rospotrebnadzor |url = https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 |date=14 October 2020 |language=ru}}</ref><ref>{{cite web | title = Russia's EpiVacCorona vaccine post-registration trials started | publisher=The Pharma Letter |url = https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started |date=18 November 2020 }}</ref>
Line 332: Line 332:


== RBD-Dimer ==
== RBD-Dimer ==
[[ZF2001|RBD-Dimer]] is a [[subunit vaccine]] produced by the Chinese company [[Anhui Zhifei Longcom Biopharmaceutical]].<ref name="london2">{{cite web|date=1 March 2021|title=COVID-19 vaccine development pipeline (Refresh URL to update)|url=https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/|access-date=10 March 2021|publisher=Vaccine Centre, London School of Hygiene and Tropical Medicine}}</ref>

;Emergency (2)
;Emergency (2)
*China<ref>{{Cite news|last=Liu|first=Roxanne|date=2021-03-15|title=China IMCAS's COVID-19 vaccine obtained emergency use approval in China|language=en|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-china-vaccine-idUSL4N2LD3BZ|url-status=live|access-date=2021-03-15}}</ref>
*China<ref>{{Cite news|last=Liu|first=Roxanne|date=2021-03-15|title=China IMCAS's COVID-19 vaccine obtained emergency use approval in China|language=en|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-china-vaccine-idUSL4N2LD3BZ|url-status=live|access-date=2021-03-15}}</ref>
Line 341: Line 341:


== CoviVac ==
== CoviVac ==
{{ill|CoviVac|ru|КовиВак}} is an [[inactivated vaccine]]<ref>{{cite news|last=Ryumin|first=Alexander|date=20 February 2021|title=Russia registers its third COVID-19 vaccine CoviVac|work=[[TASS]]|location=[[Moscow]]|url=https://tass.com/society/1258859|access-date=6 March 2021}}</ref> produced by the Chumakov Centre at the [[Russian Academy of Sciences]].<ref>{{Cite web|date=18 January 2021|title=Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova|url=http://government.ru/en/news/41342/|access-date=20 February 2021|publisher=Government of Russia}}</ref>

;Emergency (1)
;Emergency (1)
* Russia<ref>{{cite news | title=Russia approves its third COVID-19 vaccine, CoviVac |url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-its-third-covid-19-vaccine-covivac-idUKKBN2AK07H |publisher=Reuters |date=20 February 2021 }}</ref>
* Russia<ref>{{cite news | title=Russia approves its third COVID-19 vaccine, CoviVac |url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-its-third-covid-19-vaccine-covivac-idUKKBN2AK07H |publisher=Reuters |date=20 February 2021 }}</ref>

Revision as of 00:10, 18 March 2021

National regulatory authorities have granted emergency use authorizations for twelve COVID-19 vaccines. Six of those have been approved for emergency or full use by at least one WHO-recognized stringent regulatory authorities.

Overview maps

Pfizer–BioNTech

The Pfizer–BioNTech COVID-19 vaccine, also known as Comirnaty, is an RNA vaccine[1] produced by the German company BioNTech and the American company Pfizer.[2][3][4]

Emergency (36)
Full (12)

Sputnik V

The Sputnik V COVID-19 vaccine is a viral vector vaccine[67] produced by the Russan Gamaleya Research Institute of Epidemiology and Microbiology.

Emergency (44)
Full (8)

Oxford–AstraZeneca

The Oxford–AstraZeneca COVID-19 vaccine, also known as Covishield, is a viral vector vaccine[117] produced by the British University of Oxford, Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations.[118][119][120]

Emergency (42)
Full (10)

BBIBP-CorV

BBIBP-CorV is an inactivated vaccine[184] produced by the China National Pharmaceutical Group (Sinopharm).[185]

Emergency (27)
Full (4)

CoronaVac

CoronaVac is an inactivated vaccine[216] produced by the Chinese company Sinovac Biotech.[217][218][219]

Emergency (20)
Full (2)

Moderna

The Moderna COVID-19 vaccine is an RNA vaccine[239] produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations.[240][241]

Emergency (10)
Full (5)

Johnson & Johnson

The Johnson & Johnson COVID-19 vaccine is a viral vector vaccine[257] produced by the American company Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center.[258][259]

Emergency (8)
Full (5)

Convidicea

Convidicea is a viral vector vaccine[272] produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.

Emergency (2)
Full (1)

Covaxin

Covaxin is an inactivated vaccine[275] produced by the Indian company Bharat Biotech and the Indian Council of Medical Research.

Emergency (3)
Full (0)
  • None

EpiVacCorona

EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.[278]

Emergency (1)
Full (1)

RBD-Dimer

RBD-Dimer is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.[283]

Emergency (2)
Full (0)
  • None

CoviVac

CoviVac [ru] is an inactivated vaccine[287] produced by the Chumakov Centre at the Russian Academy of Sciences.[288]

Emergency (1)

Full (0)

  • None

Notes

  1. ^ a b c US authorization also includes the three sovereign nations in the Compact of Free Association: Palau, the Marshall Islands, and Micronesia.[42][43]

References

  1. ^ a b "Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine". Health Canada, Government of Canada. 9 December 2020. Retrieved 9 December 2020.
  2. ^ "Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine". Health Canada, Government of Canada. 9 December 2020. Retrieved 9 December 2020.
  3. ^ "Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults". ClinicalTrials.gov. United States National Library of Medicine. 30 April 2020. NCT04368728. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  4. ^ "A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults". EU Clinical Trials Register. European Union. 14 April 2020. EudraCT 2020-001038-36. Archived from the original on 22 April 2020. Retrieved 22 April 2020.
  5. ^ "Albania to start COVID-19 immunisation with Pfizer vaccine in January – report". Seenews.
  6. ^ "ANDORRA COVID-19". govern.ad. Retrieved 19 February 2021.
  7. ^ "Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer". La Nación (in Spanish). Retrieved 23 December 2020.
  8. ^ Overheid, Aruba (7 January 2021). "COVID-19 vaccine update". government.aw. Retrieved 19 February 2021.
  9. ^ "Bahrain becomes second country to approve Pfizer COVID-19 vaccine". Al Jazeera. Retrieved 5 December 2020.
  10. ^ a b c "Drug and vaccine authorizations for COVID-19: List of applications received". Health Canada, Government of Canada. 9 December 2020. Retrieved 9 December 2020.
  11. ^ "Pfizer vaccine approved for region but Health Ministry wants more info". Trinidad and Tobago Newsday. 6 January 2021. Retrieved 24 February 2021.
  12. ^ "Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use". The Straits Times. 17 December 2020. Retrieved 17 December 2020.
  13. ^ "Colombia regulator approves Pfizer-BioNTech vaccine for emergency use". Reuters. 6 January 2021. Retrieved 6 January 2021.
  14. ^ "Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine". The Tico Times. 16 December 2020. Retrieved 16 December 2020.
  15. ^ "Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria" (in Spanish). Retrieved 17 December 2020.
  16. ^ "Use of vaccine approved". Government of Hong Kong. 25 January 2021. Retrieved 15 February 2021.
  17. ^ "Iraq grants emergency approval for Pfizer COVID-19 vaccine". MSN. Retrieved 27 December 2020.
  18. ^ "Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine". The Jerusalem Post. Retrieved 28 December 2020.
  19. ^ "Jordan approves Pfizer-BioNTech Covid vaccine". France 24. 15 December 2020. Retrieved 15 December 2020.
  20. ^ "Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine". Arab News. 13 December 2020. Retrieved 15 December 2020.
  21. ^ "Lebanon starts Covid-19 vaccination campaign". France 24. 14 February 2021. Retrieved 16 March 2021.
  22. ^ "Liechtenstein – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 19 February 2021.
  23. ^ "Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges". Bloomberg. 12 December 2020. Retrieved 12 December 2020.
  24. ^ "Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine". The Economic Times. 12 December 2020. Retrieved 14 January 2021.
  25. ^ "FIRST VACCINES ARRIVE IN MONACO – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco". en.gouv.mc. Retrieved 19 February 2021.
  26. ^ "Robust assessment ahead of Medsafe approval of vaccine". Ministry of Health. 3 February 2021. Retrieved 6 February 2021.
  27. ^ "North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts". RadioFreeEurope/RadioLiberty. Retrieved 19 February 2021.
  28. ^ "Oman issues licence to import Pfizer BioNTech Covid vaccine – TV". Reuters. 15 December 2020. Retrieved 16 December 2020.
  29. ^ "Panama approves Pfizer's COVID-19 vaccine – health ministry". Yahoo! Finance. Retrieved 16 December 2020.
  30. ^ "PH authorizes Pfizer's COVID-19 vaccine for emergency use". CNN Philippines. 14 January 2021. Retrieved 14 January 2021.
  31. ^ "Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week". Reuters. Retrieved 24 December 2020.
  32. ^ a b c d e "Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021" (PDF). Government of Saint Vincent and the Grenadines. 11 February 2021. Retrieved 12 February 2021.
  33. ^ "Singapore approves use of Pfizer's COVID-19 vaccine". AP NEWS. 14 December 2020. Retrieved 15 December 2020.
  34. ^ "Suriname begins coronavirus vaccination campaign with donated doses". Reuters. 23 February 2021. Retrieved 28 February 2021.
  35. ^ "Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland" (Press release). Swiss Agency for Therapeutic Products (Swissmedic). 19 December 2020. Retrieved 19 December 2020.
  36. ^ "Comirnaty Product information" (in German). Retrieved 31 January 2021. [Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).]
  37. ^ "Dubai approves the Pfizer-BioNTech vaccine which will be free of charge". Emirates Woman. 23 December 2020. Retrieved 28 December 2020.
  38. ^ Decree of Ministry of Health of Ukraine on approval Covishield and Comirnaty vaccines
  39. ^ "UK medicines regulator gives approval for first UK COVID-19 vaccine". Medicines and Healthcare Products Regulatory Agency, Government of the UK. 2 December 2020. Retrieved 2 December 2020.
  40. ^ "Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine". Medicines & Healthcare products Regulatory Agency (MHRA). 8 December 2020. Retrieved 13 December 2020.
  41. ^ "Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine". Medicines & Healthcare products Regulatory Agency (MHRA). 3 December 2020. Retrieved 13 December 2020.
  42. ^ "Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines" (Press release). United States Department of the Interior (DOI). 12 December 2020. Retrieved 13 January 2021. Public Domain This article incorporates text from this source, which is in the public domain.
  43. ^ Dorman B (6 January 2021). "Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID". Hawaii Public Radio. Retrieved 13 January 2021.
  44. ^ "FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine" (Press release). U.S. Food and Drug Administration (FDA). 11 December 2020. Retrieved 11 December 2020. Public Domain This article incorporates text from this source, which is in the public domain.
  45. ^ "Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers" (PDF). Pfizer. 25 February 2021. Retrieved 25 February 2021.
  46. ^ McElwee, Joshua J. (11 December 2020). "Vatican to offer coronavirus vaccine to residents and staff in early 2021". National Catholic Reporter. Retrieved 9 February 2021.
  47. ^ Menichetti, Massimiliano (11 December 2020). "In Vaticano parte il piano vaccinale anticovid". vatican.va (Press release). Retrieved 9 February 2021.
  48. ^ a b "Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process" (PDF). World Health Organization (WHO).
  49. ^ "WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access". World Health Organization (WHO) (Press release). 31 December 2020. Retrieved 6 January 2021.
  50. ^ "Comirnaty". Therapeutic Goods Administration. 25 January 2021. Retrieved 25 January 2021.
  51. ^ Australian Public Assessment Report for BNT162b2 (mRNA) (PDF) (Report). Therapeutic Goods Administration (TGA). Retrieved 25 January 2021.
  52. ^ "Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil" (in Brazilian Portuguese). G1. 23 February 2021. Retrieved 23 February 2021.
  53. ^ "Comirnaty EPAR". European Medicines Agency (EMA). Retrieved 23 December 2020.
  54. ^ "Questions and Answers: COVID-19 vaccination in the EU". European Commission. 21 December 2020. Retrieved 21 December 2020.
  55. ^ "Comirnaty". Union Register of medicinal products. Retrieved 8 January 2021.
  56. ^ a b "Første vaccine mod COVID19 godkendt i EU". Lægemiddelstyrelsen (in Danish). Retrieved 26 December 2020.
  57. ^ "COVID-19: Bóluefninu Comirnaty frá BioNTech/Pfizer hefur verið veitt skilyrt íslenskt markaðsleyfi". Lyfjastofnun (in Icelandic). Retrieved 26 December 2020.
  58. ^ "Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use". Nikkei Asia. 14 February 2021. Retrieved 14 February 2021.
  59. ^ Lim I (8 January 2021). "Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted". The Malay Mail. Retrieved 8 January 2021.
  60. ^ "Status på koronavaksiner under godkjenning per 21.12.20". Statens legemiddelverk (in Norwegian Bokmål). Retrieved 26 December 2020.
  61. ^ "Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use". Al Arabiya English. 10 December 2020. Retrieved 10 December 2020.
  62. ^ Zimmer C, Corum J, Wee SL (10 June 2020). "Coronavirus Vaccine Tracker". The New York Times. Retrieved 12 December 2020.
  63. ^ "Serbia leads region in expecting COVID-19 vaccines within days". BalkanInsight. 21 December 2020. Retrieved 26 December 2020.
  64. ^ "First shipment of Pfizer-BioNTech vaccine arrives in Serbia". Serbian government website. 22 December 2020. Retrieved 26 December 2020.
  65. ^ Lee, Kyung-eun (27 February 2021). "S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program". Arirang News. Retrieved 28 February 2021.
  66. ^ Kim, Han-joo (5 March 2021). "S. Korea approves Pfizer's COVID-19 vaccine amid immunization push". Yonhap News Agency. Retrieved 5 March 2021.
  67. ^ "An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 17 June 2020. NCT04436471. Retrieved 5 March 2021.
  68. ^ "Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine". Algeria Press service. 10 January 2021.
  69. ^ "Argentina has registered the Sputnik V vaccine based on Russian clinical trial data" (Press release). Gamaleya Center. Retrieved 1 January 2021.
  70. ^ "Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF". Reuters. 1 February 2021. Retrieved 1 February 2021.
  71. ^ "Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV". Reuters. 10 February 2021. Retrieved 19 February 2021.
  72. ^ "Belarus registers Sputnik V vaccine, in first outside Russia – RDIF". Reuters. 21 December 2020. Retrieved 22 December 2020.
  73. ^ "Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19". minsalud.gob.bo. Retrieved 1 January 2021.
  74. ^ a b "COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs". Gulf News. Retrieved 24 February 2021.
  75. ^ "Sputnik V authorised in Gabon" (Press release). Gamaleya Center. Retrieved 17 February 2021.
  76. ^ "Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF". Reuters. 20 February 2021.
  77. ^ "Guatemala to receive Russia's Sputnik vaccine in coming weeks". Reuters. 24 February 2021.
  78. ^ "Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine". Africa news. 31 December 2020.
  79. ^ "Russia's Sputnik V vaccine expands its reach in Latin America". CNN. 3 March 2021.
  80. ^ "Honduras approves use of Sputnik V vaccine against COVID-19". Xinhua News Agency. 25 February 2021.
  81. ^ "Iran approves Russian coronavirus vaccine Sputnik V". Reuters. 26 January 2021.
  82. ^ "Sputnik V authorized in Iraq" (Press release). PharmiWeb.com. 4 March 2021.
  83. ^ https://apnews.com/article/europe-italy-coronavirus-pandemic-russia-1c9bac0105f04e297e51f04859f304a9
  84. ^ "Jordan approves Russia's Sputnik V vaccine for use against COVID-19" (Press release). Reuters. 10 March 2021.
  85. ^ "Kazakhstan begins mass vaccination by Russian Sputnik V". 1 February 2021. Retrieved 19 February 2021.
  86. ^ "Morocco, Kenya approve Russian coronavirus vaccine for use - RDIF". 10 March 2021. Retrieved 12 March 2021.
  87. ^ a b "Laos declares Covid-19 vaccinations safe, more to be inoculated next week | The Star". The Star. Malaysia. Retrieved 19 February 2021.
  88. ^ "Lebanon authorises emergency use of Russia's Sputnik V vaccine". Reuters. 5 February 2021.
  89. ^ "Mexico, Germany warm to Russia's Sputnik V virus vaccine". The Jakarta Post. 3 February 2021.
  90. ^ "Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF". Urdu Point. 9 February 2021.
  91. ^ "Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF". Reuters. 12 February 2021.
  92. ^ "Morocco orders one million doses of Russia's Sputnik V vaccine". Yabiladi. 11 March 2021.
  93. ^ "Myanmar registers Russia's Sputnik V COVID-19 vaccine". TASS. Retrieved 19 February 2021.
  94. ^ "Nicaragua approves Russian COVID-19 vaccine". wsoctv. 3 February 2021.
  95. ^ "NRussia's Sputnik V COVID 19 vaccine registered in North Macedonia". TASS. 7 March 2021.
  96. ^ "Govt okays Russian vaccine for 'emergency use'". Dawn. 24 January 2021.
  97. ^ "Palestine has become the first country in the Middle East to register Sputnik V vaccine". RFID. 11 January 2021.
  98. ^ "Paraguay approves Russia's Sputnik V vaccine: RDIF". Reuters. 15 January 2021. Retrieved 15 January 2021.
  99. ^ a b c "Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska". TASS. 5 February 2021. Retrieved 8 February 2021.
  100. ^ Burki TK (November 2020). "The Russian vaccine for COVID-19". The Lancet. Respiratory Medicine. 8 (11): e85–e86. doi:10.1016/S2213-2600(20)30402-1. PMC 7837053. PMID 32896274.
  101. ^ "San Marino buys the Sputnik vaccine: "First doses already in the next few days"". Unioneonline. 20 February 2021.
  102. ^ "Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju". N1 (in Serbian). 31 December 2020.
  103. ^ "Sputnik V approved for use in Slovakia". rdif.ru. Retrieved 1 March 2021.
  104. ^ "Sri Lanka approves Russia's Sputnik V vaccine". The Hindu. 4 March 2021.
  105. ^ "Sputnik V vaccine authorized in Tunisia" (Press release). Gamaleya Center. Retrieved 30 January 2021.
  106. ^ "UAE approves Russia's Sputnik vaccine for emergency use". Khaleej Times. 21 January 2021. Retrieved 21 January 2021.
  107. ^ "Uruguay to start covid 19 Vaccination in April 2021". India Blooms.
  108. ^ "Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V" (in Spanish). Reuters. 29 December 2020.
  109. ^ a b "Vietnam approves US, Russia Covid-19 vaccines for emergency use". VnExpress. Retrieved 26 February 2021.
  110. ^ a b "Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use". news24.com. 9 March 2021.
  111. ^ a b c "Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine". Reuters. 3 March 2021.
  112. ^ "Hungarian drug regulator approves Sputnik V vaccine: website". The Moscow Times. 7 February 2021.
  113. ^ "Sputnik V registered in Kyrgyzstan". Gamaleya Center (Press release). 23 February 2021.
  114. ^ "Syria authorizes use of Sputnik-V". Roya. 22 February 2021.
  115. ^ "Turkmenistan is the first in Central Asia to have registered "Sputnik V" vaccine". Orient. 18 January 2021.
  116. ^ "Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use". Agence France-Presse (Barron's). 17 February 2021.
  117. ^ "Investigating a Vaccine Against COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 26 May 2020. NCT04400838. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  118. ^ "Investigating a Vaccine Against COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 26 May 2020. NCT04400838. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  119. ^ "A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register. European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved 3 August 2020.
  120. ^ O'Reilly P (26 May 2020). "A Phase III study to investigate a vaccine against COVID-19". ISRCTN. doi:10.1186/ISRCTN89951424. ISRCTN89951424.
  121. ^ Sediqi, Abdul Qadir (7 February 2021). "First doses of COVID-19 vaccine arrive in Afghanistan from India". Reuters. Retrieved 24 February 2021.
  122. ^ "India donates 500,000 COVID vaccines to Afghanistan". Al Jazeera. Retrieved 24 February 2021.
  123. ^ a b c "Informació en relació amb la vacunació contra la COVID-19" (PDF). Govern d’Andorra. Retrieved 14 March 2021.
  124. ^ "Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine". Reuters. 30 December 2020. Retrieved 30 December 2020.
  125. ^ "Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India". Saudigazette. 25 January 2021. Retrieved 30 January 2021.
  126. ^ "Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use". The Daily Star. Retrieved 6 January 2021.
  127. ^ "Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine". aa.com.tr. Retrieved 6 January 2021.
  128. ^ "La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19". Agencia EFE (in Spanish). 31 December 2020.
  129. ^ "Ecuador approves use of AstraZeneca vaccine for COVID-19". Reuters. 24 January 2021. Retrieved 30 January 2021.
  130. ^ "El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine". Reuters. 30 December 2020.
  131. ^ https://www.afro.who.int/news/arrival-covax-vaccines-raises-hope-gambia
  132. ^ https://www.aa.com.tr/en/africa/ethiopia-begins-covid-19-vaccine-rollout/2174904
  133. ^ https://www.afro.who.int/news/ethiopia-introduces-covid-19-vaccine-national-launching-ceremony
  134. ^ https://www.reuters.com/article/us-health-coronavirus-ethiopia-idUSKBN2A916S
  135. ^ "Guyana gets first batch of COVID-19 vaccines; CARICOM Secretariat to get 100 doses". 10 February 2021. Retrieved 19 February 2021.
  136. ^ "Nurse administers first shot of AstraZeneca ( ChAdOx1 nCoV-19, ) vaccine to Brinnet Bernarai at Georgetown Public Hospital Corporation – PAHO/WHO | Pan American Health Organization". paho.org. Retrieved 19 February 2021.
  137. ^ a b Schmall E, Yasir S (3 January 2021). "India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other". The New York Times. Retrieved 3 January 2021.
  138. ^ "BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca". Kompas.com. Retrieved 10 February 2021.
  139. ^ a b "Iraq approves Sinopharm, AstraZeneca vaccines". Big News Network.com. Retrieved 30 January 2021.
  140. ^ https://www.bbc.com/news/world-africa-56239136
  141. ^ https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first
  142. ^ http://www.xinhuanet.com/english/2021-02/02/c_139716241.htm
  143. ^ https://www.voanews.com/covid-19-pandemic/malawi-sticks-astrazeneca-despite-concerns-over-efficacy
  144. ^ "Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua | English.news.cn". Xinhua News Agency. Retrieved 19 February 2021.
  145. ^ AfricaNews (26 January 2021). "Mauritius begins vaccinating frontline health workers against covid-19". Africanews. Retrieved 24 February 2021.
  146. ^ "Mexico approves AstraZeneca COVID-19 vaccine, minister says". Reuters. 5 January 2021. Retrieved 14 January 2021.
  147. ^ "Myanmar launches nationwide COVID-19 vaccination program". Xinhua News. 27 January 2021.
  148. ^ "Nepal approves AstraZeneca COVID vaccine for emergency use – government statement". Reuters. 15 January 2021.
  149. ^ "Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria". BBC News Pidgin. Retrieved 24 February 2021.
  150. ^ "Pakistan approves AstraZeneca COVID-19 vaccine for emergency use". 16 January 2021.
  151. ^ "Philippine regulator approves emergency use of AstraZeneca vaccine". Reuters. 28 January 2021. Retrieved 28 January 2021.
  152. ^ https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax
  153. ^ a b "AstraZeneca and Moderna vaccines to be administered in Saudi Arabia". Gulf News. Retrieved 19 January 2021.
  154. ^ https://www.reuters.com/article/health-coronavirus-serbia-vaccines-idUSL1N2KR03M
  155. ^ https://www.afro.who.int/news/covid-19-vaccines-shipped-covax-arrive-sierra-leone
  156. ^ "Sri Lanka approves vaccine amid warnings of virus spread". AP NEWS. 22 January 2021. Retrieved 22 January 2021.
  157. ^ https://www.unicef.org/sudan/stories/covid-19-vaccination-sudan
  158. ^ https://www.unicef.org/press-releases/sudan-receives-first-delivery-covid-19-vaccines-over-800000-doses
  159. ^ "Suriname begins coronavirus vaccination campaign with donated doses". Reuters. 23 February 2021. Retrieved 28 February 2021.
  160. ^ "Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine". Reuters. 20 February 2021. Retrieved 13 March 2021.
  161. ^ "Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca". Pattaya Mail. 23 January 2021.
  162. ^ https://www.togofirst.com/en/health/1602-7300-covid-19-first-vaccination-campaign-to-soon-begin
  163. ^ https://www.africanews.com/2021/03/10/uganda-starts-covid-19-vaccinations/
  164. ^ "COVID-19: AstraZeneca vaccine certified for use in Ukraine". covid.unian.info. Retrieved 10 March 2021.
  165. ^ "Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Retrieved 4 January 2021.
  166. ^ "Oxford University/AstraZeneca vaccine authorised by UK medicines regulator" (Press release). Department of Health and Social Care. 30 December 2020. Retrieved 30 December 2020.
  167. ^ "Conditions of Authorisation for COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Retrieved 4 January 2021.
  168. ^ "Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress". CNA. Retrieved 5 February 2021.
  169. ^ "Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca". World Health Organization (WHO). Retrieved 27 February 2021.
  170. ^ "AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO". Forbes. Retrieved 16 February 2021.
  171. ^ "AstraZeneca coronavirus vaccine approved for use in Australia by TGA". ABC News. 16 February 2021. Retrieved 16 February 2021.
  172. ^ "TGA provisionally approves AstraZeneca's COVID-19 vaccine". Therapeutic Goods Administration (TGA). 16 February 2021. Retrieved 16 February 2021.
  173. ^ "Brazil grants full approval to Oxford vaccine, orders Sputnik". France 24. Brasilia. Agence France-Presse. 12 March 2021. Retrieved 13 March 2021.
  174. ^ "Regulatory Decision Summary – AstraZeneca COVID-19 Vaccine". Health Canada. 26 February 2021. Retrieved 26 February 2021.
  175. ^ "COVID-19 Vaccine AstraZeneca: Pending EC decision". European Medicines Agency (EMA). 28 January 2021. Retrieved 29 January 2021.
  176. ^ "EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU". European Medicines Agency (EMA) (Press release). 29 January 2021. Retrieved 29 January 2021.
  177. ^ "European Commission authorises third safe and effective vaccine against COVID-19". European Commission (Press release). 29 January 2021. Retrieved 29 January 2021.
  178. ^ a b "EU-Kommissionen har i dag udstedt en betinget markedsføringstilladelse til AstraZeneca COVID-19- vaccine. Tilladelsen gælder i Danmark". Lægemiddelstyrelsen (in Danish). Retrieved 12 March 2021.
  179. ^ "The Icelandic Medicines Agency have issued a conditional marketing authorisation for the AstraZeneca COVID-19 vaccine". covid.is. Retrieved 12 March 2021.
  180. ^ a b Sipalan, Joseph; Donovan, Kirsten (3 March 2021). "Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use". Reuters. Retrieved 7 March 2021.
  181. ^ "The European Commission has now approved the AstraZeneca COVID-19 vaccine. This means that the vaccine is approved for use in Norway". vg. Retrieved 12 March 2021.
  182. ^ Kim, Han-joo (10 February 2021). "S. Korea approves AstraZeneca's COVID-19 vaccine for all adults". Yonhap News Agency. Retrieved 10 February 2021.
  183. ^ Maresca, Thomas (10 February 2021). "South Korea approves AstraZeneca COVID-19 vaccine". United Press International. Retrieved 10 February 2021.
  184. ^ Chen W, Al Kaabi N (18 July 2020). "A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)". Chinese Clinical Trial Registry. Retrieved 15 August 2020.
  185. ^ Chen W, Al Kaabi N (18 July 2020). "A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)". Chinese Clinical Trial Registry. Retrieved 15 August 2020.
  186. ^ Biannchi, Walter (21 February 2021). "Argentina approves Sinopharm COVID-19 vaccine for emergency use". Reuters. Retrieved 23 February 2021.
  187. ^ "Belarus begins COVID-19 vaccinations with Chinese shots". Belta. 15 March 2021. Retrieved 16 March 2021.
  188. ^ "Bolivia begins inoculation with Sinopharm jabs | The Star". The Star. Malaysia. Retrieved 28 February 2021.
  189. ^ Rinith T (4 February 2021). "Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine". Khmer Times. Retrieved 4 February 2021.
  190. ^ "Dominica: Melissa Skerrit receives the Sinopharm COVID-19 vaccine". WIC News. 4 March 2021. Retrieved 7 March 2021.
  191. ^ "Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua | English.news.cn". Xinhua News Agency.
  192. ^ "Gabon receives 100,000 doses of Sinopharm's vaccine from China". Gabon 24. 12 March 2021. Retrieved 15 March 2021.
  193. ^ "Sinopharm vaccine rollout starts this weekend". Stabroek News. 6 March 2021. Retrieved 7 March 2021.
  194. ^ "Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU". National Post.
  195. ^ "Iran Launches Phase Two of Mass Inoculation Campaign". Financial Tribune. 22 February 2021. Retrieved 23 February 2021.
  196. ^ "First batch of Chinese Sinopharm vaccine arrives in Jordan". Roya News. Retrieved 9 January 2021.
  197. ^ Crean, Rosabel. "China donates 50,000 doses of Sinopharm vaccine to Lebanon | News , Lebanon News | THE DAILY STAR". Daily Star. Retrieved 2 March 2021.
  198. ^ "Macau receives first batch of COVID-19 vaccines". IAG. 7 February 2021. Retrieved 24 February 2021.
  199. ^ Rasheed, Aishath Hanaan Hussain. "MFDA approves Pfizer, Sinopharm Covid-19 vaccines for emergency use". raajje.mv. Retrieved 16 March 2021.
  200. ^ "Deputy PM and City Governor get the first dose of Sinopharm vaccine". MONTSAME News Agency. Retrieved 15 March 2021.
  201. ^ "Covid-19: Morocco authorizes use of the Sinopharm vaccine". en.yabiladi.com.
  202. ^ Reuters Staff (6 March 2021). "Mozambique expects to vaccinate 16 million against coronavirus by 2022". Reuters. Retrieved 7 March 2021. {{cite web}}: |author= has generic name (help)
  203. ^ Poudel, Arjun. "China's Shinopharm vaccine gets emergency use authorisation in Nepal". Kathmandu Post. Retrieved 19 February 2021.
  204. ^ Shahzad A (19 January 2021). "Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use". Reuters.
  205. ^ "Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources". Reuters. 27 January 2021.
  206. ^ Asala, Kizzi. "Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm". Africanews. Retrieved 23 February 2021.
  207. ^ "Serbia Becomes First European Nation To Use China's Sinopharm Vaccine". RadioFreeEurope/RadioLiberty.
  208. ^ Thomas, Abdul Rashid (15 March 2021). "Sierra Leone's President Bio leads the way in taking COVID-19 Vaccine". Sierra Leone Telegraph. Retrieved 16 March 2021.
  209. ^ Sequera, Vivian (1 March 2021). "Venezuela approves use of China's Sinopharm coronavirus vaccine". Reuters. Retrieved 2 March 2021.
  210. ^ Mutsaka, Farai (18 February 2021). "Zimbabwe starts administering China's Sinopharm vaccines". The Star. Retrieved 20 February 2021.
  211. ^ "Bahrain approves China's Sinopharm coronavirus vaccine". Arabian Business Industries. 13 December 2020.
  212. ^ Kuo L. "China approves Sinopharm coronavirus vaccine, the country's first for general use". The Washington Post.
  213. ^ "President Ramkalawan and First Lady receives second dose SinoPharm Vaccine". statehouse.gov.sc. Retrieved 5 February 2021.
  214. ^ Wee SL (9 December 2020). "Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl". The New York Times. Retrieved 12 December 2020.
  215. ^ "Coronavirus: UAE authorises emergency use of vaccine for frontline workers". The National. Retrieved 24 November 2020.
  216. ^ "Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)". ClinicalTrials.gov. United States National Library of Medicine. 12 May 2020. NCT04383574. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  217. ^ "Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)". ClinicalTrials.gov. United States National Library of Medicine. 12 May 2020. NCT04383574. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  218. ^ "Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)". ClinicalTrials.gov. United States National Library of Medicine. 2 July 2020. NCT04456595. Archived from the original on 11 October 2020. Retrieved 3 August 2020.
  219. ^ PT. Bio Farma (10 August 2020). "A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia". Registri Penyakit Indonesia. Retrieved 15 August 2020.
  220. ^ Aliyev J. "Azerbaijan kicks off COVID-19 vaccination". Anadolu Agency. Retrieved 7 February 2021.
  221. ^ "Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19". noticias.uol.com.br (in Brazilian Portuguese). Retrieved 6 January 2021.
  222. ^ McGeever J, Fonseca P (17 January 2021). "Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin". Reuters. Retrieved 17 January 2021.
  223. ^ Chanritheara, Torn. "Cambodia Approves AstraZeneca and Sinovac Vaccines for COVID-19 Emergency Use". Cambodianess. Retrieved 12 February 2021.
  224. ^ "Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19". France 24. 20 January 2021. Retrieved 30 January 2021.
  225. ^ Aliyev J. "Colombia approves emergency use of CoronaVac vaccine". Anadolu Agency. Retrieved 7 February 2021.
  226. ^ "Anticovid vaccines run out as Dominican Republic awaits arrival of more doses". DominicanToday. Retrieved 10 March 2021.
  227. ^ "Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister". National Post. Retrieved 26 February 2021.
  228. ^ "Use of Sinovac vaccine authorised". Government of Hong Kong. 18 February 2021. Retrieved 19 February 2021.
  229. ^ Soeriaatmadja W (11 January 2021). "Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy". The Straits Times. Retrieved 11 January 2021.
  230. ^ "BPOM Grants Emergency Use Authorization for Sinovac Vaccine". Tempo. 11 January 2021. Retrieved 11 January 2021.
  231. ^ a b c Liu R (6 February 2021). "China approves Sinovac Biotech COVID-19 vaccine for general public use". Reuters. Retrieved 7 February 2021.
  232. ^ a b Barrera, Adriana (11 February 2021). "Mexico approves China's CanSino and Sinovac COVID-19 vaccines". Reuters. Retrieved 11 February 2021.
  233. ^ "CoronaVac, vacuna de alta eficacia". Ministerio de Salud Publica Y Bienestar Social.{{cite web}}: CS1 maint: url-status (link)
  234. ^ "Philippines approves Sinovac's COVID-19 vaccine for emergency use". Reuters. 22 February 2021.
  235. ^ Thepgumpanat, Panarat (22 February 2021). "Thailand allows emergency use of Sinovac's COVID-19 vaccine". Reuters. Retrieved 23 February 2021.
  236. ^ "Tunisia approva vaccino cinese Sinovac" (in Italian). Agenzia Nazionale Stampa Associata (in Italian). 5 March 2021. Retrieved 7 March 2021.
  237. ^ "Turkey to begin COVID-19 vaccine jabs by this weekend". Anadolu. 11 January 2021. Retrieved 11 January 2021.
  238. ^ Zinets, Natalia (9 March 2021). "Ukraine approves China's Sinovac COVID-19 vaccine". Reuters. Retrieved 10 March 2021.
  239. ^ "Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)". ClinicalTrials.gov. United States National Library of Medicine. 16 March 2020. NCT04283461. Retrieved 5 March 2021.
  240. ^ "A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 14 July 2020. NCT04470427. Archived from the original on 11 October 2020. Retrieved 27 July 2020.
  241. ^ Palca J (27 July 2020). "COVID-19 vaccine candidate heads to widespread testing in U.S." NPR. Archived from the original on 11 October 2020. Retrieved 27 July 2020.
  242. ^ "Regulatory Decision Summary – Moderna COVID-19 Vaccine". Health Canada, Government of Canada. 23 December 2020. Retrieved 23 December 2020.
  243. ^ "Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". modernatx.com. 4 January 2021. Retrieved 4 January 2021.
  244. ^ "Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine". Reuters. 3 February 2021. Retrieved 3 February 2021.
  245. ^ "Swissmedic grants authorisation for the COVID-19 vaccine from Moderna" (Press release). Swiss Agency for Therapeutic Products (Swissmedic). 12 January 2020. Retrieved 12 January 2020.
  246. ^ "Information for Healthcare Professionals on COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 8 January 2021.
  247. ^ "Conditions of Authorisation for COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 9 January 2021.
  248. ^ "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). Retrieved 18 December 2020.
  249. ^ Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, et al. (December 2020). "The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine – United States, December 2020" (PDF). MMWR. Morbidity and Mortality Weekly Report. 69 (5152): 1653–56. doi:10.15585/mmwr.mm695152e1. PMID 33382675. S2CID 229945697.
  250. ^ "COVID-19 Vaccine Moderna EPAR". European Medicines Agency (EMA). Retrieved 20 January 2021.
  251. ^ "European Commission authorises second safe and effective vaccine against COVID-19". European Commission (Press release). Retrieved 6 January 2021.
  252. ^ "EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU" (Press release). European Medicines Agency. 6 January 2021. Retrieved 6 January 2021.
  253. ^ "COVID-19 Vaccine Moderna". Union Register of medicinal products. Retrieved 14 January 2021.
  254. ^ a b "Endnu en vaccine mod COVID-19 er godkendt af EU-Kommissionen". Lægemiddelstyrelsen (in Danish). Retrieved 7 January 2021.
  255. ^ "COVID-19: Bóluefninu COVID-19 Vaccine Moderna frá hefur verið veitt skilyrt íslenskt markaðsleyfi". Lyfjastofnun (in Icelandic). Retrieved 7 January 2021.
  256. ^ "Status på koronavaksiner under godkjenning per 6. januar 2021". Statens legemiddelverk (in Norwegian Bokmål). Retrieved 7 January 2021.
  257. ^ Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19 (Briefing). Food and Drug Administration. 26 February 2021. p. 6. Retrieved 6 March 2021. The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein.
  258. ^ "A Study of Ad26.COV2.S in Adults". ClinicalTrials.gov. 4 August 2020. Archived from the original on 16 September 2020. Retrieved 23 August 2020.
  259. ^ "A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants". ClinicalTrials.gov. US National Library of Medicine. Archived from the original on 26 September 2020.
  260. ^ "Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use". Reuters. 25 February 2021. Retrieved 25 February 2021.
  261. ^ "Bahrain becomes 1st nation to grant J&J shot emergency use". ABC News. 25 February 2021. Retrieved 25 February 2021.
  262. ^ "Johnson & Johnson COVID-19 vaccine becomes 4th to receive Health Canada approval | CBC News". Canadian Broadcasting Corporation. Retrieved 5 March 2021.
  263. ^ https://www.jnj.com/johnson-johnson-single-shot-covid-19-vaccine-granted-conditional-marketing-authorization-by-european-commission
  264. ^ "Coronavirus: South Africa rolls out vaccination programme". BBC News. 17 February 2021. Retrieved 19 February 2021.
  265. ^ "FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). 27 February 2021. Retrieved 27 February 2021.
  266. ^ https://www.fda.gov/media/146303/download
  267. ^ "WHO approves J&J's COVID-19 vaccine for emergency listing". Channel News Asia. March 13, 2021. Retrieved March 13, 2021.
  268. ^ "European Commission authorises fourth safe and effective vaccine against COVID-19". European Commission (Press release). 11 March 2021.
  269. ^ a b "EU-Kommissionen har i dag udstedt en betinget markedsføringstilladelse til Johnson & Johnsons COVID-19- vaccine. Tilladelsen gælder i Danmark". Lægemiddelstyrelsen (in Danish). Retrieved 12 March 2021.
  270. ^ "The Icelandic Medicines Agency have issued a conditional marketing authorisation". covid.is. Retrieved 12 March 2021.
  271. ^ "The European Commission has now approved the Johnson & Johnson vaccine. This means that the vaccine is approved for use in the EU and Norway". vg. Retrieved 12 March 2021.
  272. ^ Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, et al. (August 2020). "Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial". Lancet. 396 (10249): 479–88. doi:10.1016/s0140-6736(20)31605-6. ISSN 0140-6736. PMC 7836858. PMID 32702299. {{cite journal}}: Unknown parameter |lay-url= ignored (help)
  273. ^ Shahzad, Asif (12 February 2021). "Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use". Reuters. Retrieved 12 February 2021.
  274. ^ "China approves two more domestic COVID-19 vaccines for public use". Reuters. February 25, 2021. Retrieved March 16, 2021.
  275. ^ "Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers". ClinicalTrials.gov. NCT04471519.
  276. ^ "Iran issues permit for emergency use for three other COVID-19 vaccines: Official". IRNA English. 17 February 2021.
  277. ^ Manral, Karan (4 March 2021). "Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine". Hindustan Times. Retrieved 6 March 2021.{{cite news}}: CS1 maint: url-status (link)
  278. ^ "Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)". ClinicalTrials.gov. United States National Library of Medicine. 22 September 2020. NCT04368988. Retrieved 16 November 2020.
  279. ^ "О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона"". Rospotrebnadzor (in Russian). 14 October 2020.
  280. ^ "Russia's EpiVacCorona vaccine post-registration trials started". The Pharma Letter. 18 November 2020.
  281. ^ "Turkmenistan registers vaccines for the prevention of infectious diseases". Turkmenistan Today. 29 January 2021.
  282. ^ "Russian vaccine "EpiVacCorona" was registered in Turkmenistan". EN24. 29 January 2021.
  283. ^ "COVID-19 vaccine development pipeline (Refresh URL to update)". Vaccine Centre, London School of Hygiene and Tropical Medicine. 1 March 2021. Retrieved 10 March 2021.
  284. ^ Liu, Roxanne (2021-03-15). "China IMCAS's COVID-19 vaccine obtained emergency use approval in China". Reuters. Retrieved 2021-03-15.{{cite news}}: CS1 maint: url-status (link)
  285. ^ Mamatkulov, Mukhammadsharif (1 March 2021). "Uzbekistan approves Chinese-developed COVID-19 vaccine". Reuters. Retrieved 2 March 2021.
  286. ^ "Uzbekistan certifies Chinese vaccine to fight against COVID-19". China Daily. 2 March 2021. Retrieved 8 March 2021.
  287. ^ Ryumin, Alexander (20 February 2021). "Russia registers its third COVID-19 vaccine CoviVac". TASS. Moscow. Retrieved 6 March 2021.
  288. ^ "Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova". Government of Russia. 18 January 2021. Retrieved 20 February 2021.
  289. ^ "Russia approves its third COVID-19 vaccine, CoviVac". Reuters. 20 February 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=List_of_COVID-19_vaccine_authorizations&oldid=1012727728"